Flag-IDA
FL - Fludarabine
A - Cytarabine (Ara-C)
G - Granulocyte colony stimulating factor (G-CSF, filgrastim)
IDA - Idarubicin
Indications :
| - Treatment for Acute Myeloid Leukemia (AML)/Acute Lymphocytic Leukemia (ALL)/Myelodysplastic Syndrome (MDS). May be curative of induction to put the leukemia in remission for BMT. |
|---|
Contraindications:
Dosing :
- Fludarabine intravenous (I.V.) infusion over 30 minutes on Days 1, 2, 3, 4 and 5
- Cytarabine I.V. infusion over four hours (starting four hours after fludarabine) on Days 1, 2, 3, 4 and 5
- Idarubicin IVP over 10-15 minutes on Days 1, 2 and 3
- G-CSF (Filgrastim) subcutaneous injection once daily starting 24 hours either the day before or the day of chemotherapy, and continuing daily until Day 5. In some instances, G-CSF may be restarted seven days after chemotherapy and continued until the neutrophil count returns to normal range
- Since fludarabine and cytarabine must be separated by four hours, it can take up to 9 hours to finish treatment each day
MoA :
Pharmacokinetics :
Toxicities/Monitoring :
References:
Created on: Saturday 11-11-2023